comorbid
promot
progress
alzheim
diseas
ad
remain
uncov
evalu
anim
model
elderli
individu
vulner
viral
bacteri
infect
microbi
agent
may
consid
import
comorbid
could
potenti
alreadi
exist
tenuou
inflammatori
condit
brain
acceler
cognit
declin
particularli
cellular
molecular
mechan
defin
research
recent
demonstr
trigger
inflamm
brain
exacerb
tau
patholog
characterist
anim
model
herein
explor
whether
inflamm
induc
via
viral
infect
compar
inflamm
induc
via
bacteri
lipopolysaccharid
modul
adlik
patholog
featur
mous
model
provid
evid
support
hypothesi
infecti
agent
may
act
comorbid
ad
studi
show
infectioninduc
acut
chronic
inflamm
significantli
exacerb
tau
patholog
characterist
chronic
inflamm
lead
impair
spatial
memori
tau
phosphoryl
increas
via
glycogen
synthas
mechan
promin
shift
tau
detergentsolubl
detergentinsolubl
fraction
chronic
inflamm
found
inhibit
glycogen
synthas
activ
lithium
reduc
tau
phosphoryl
accumul
insolubl
tau
revers
memori
impair
taken
togeth
infecti
agent
trigger
central
nervou
system
inflamm
may
serv
comorbid
ad
lead
cognit
impair
mechan
involv
exacerb
tau
patholog
characterist
alzheim
diseas
ad
progress
neurodegen
disord
lead
caus
dementia
afflict
million
individu
worldwid
ad
brain
display
sever
characterist
patholog
featur
includ
buildup
amyloid
plaqu
compos
also
accumul
intracellularli
neurofibrillari
tangl
compos
hyperphosphoryl
tau
protein
neuron
loss
dystroph
neurit
dendrit
spine
loss
critic
chang
well
document
ad
addit
inflamm
evidenc
reactiv
glial
cell
surround
amyloid
plaqu
consist
observ
ad
brain
factor
molecular
mechan
affect
pathogenesi
ad
still
remain
larg
unknown
although
wide
accept
disord
multifactori
certain
factor
insult
hypoxia
brain
ischemia
stress
dysregul
brain
homeostasi
physiolog
function
may
increas
suscept
develop
ad
comorbid
factor
thu
decad
research
epidemiolog
postmortem
ad
brain
suggest
viral
bacteri
infect
may
contribut
onset
ad
improv
quantit
analyt
method
sever
viral
bacteri
gene
includ
herp
simplex
viru
chlamydia
pneumonia
helicobact
pylori
isol
ad
brain
report
presenc
gene
ad
brain
statist
significantli
higher
nonad
brain
evid
vivo
vitro
studi
indic
infect
significantli
exacerb
adlik
patholog
chang
suggest
infectionmedi
alter
ie
alter
immun
respons
brain
may
increas
suscept
develop
ad
later
life
brain
inflammatori
respons
may
contribut
pathogen
process
neuroinflamm
ad
brain
like
play
benefici
harm
role
exampl
chronic
inflamm
cytokin
upregul
induc
tau
hyperphosphoryl
prepatholog
mice
addit
studi
indic
inflammatori
process
involv
clear
degrad
deposit
defici
chemokin
receptor
impair
microglia
accumul
increas
deposit
amyloid
precursor
protein
app
transgen
mice
indic
role
microglia
regul
accumul
hand
chronic
lipopolysaccharid
lp
induc
neuroinflamm
increas
intraneuron
load
transgen
mice
possibl
releas
proinflammatori
cytokin
toxic
speci
subsequ
exacerb
adrel
patholog
featur
collect
infect
neuroinflamm
may
well
link
ad
may
play
key
role
acceler
onset
develop
diseas
studi
investig
role
viral
bacteri
infect
develop
ad
phenotyp
mous
model
viral
infect
mous
hepat
viru
mhv
lp
mimic
bacteri
infect
induc
robust
transient
neuroinflamm
exacerb
tau
patholog
characterist
compromis
cognit
function
age
mice
lp
inject
caus
increas
tau
phosphoryl
partit
detergentinsolubl
fraction
indic
buildup
aggreg
tau
neuron
aberr
activ
glycogen
synthas
kinas
gsk
concomitantli
detect
mice
appear
one
main
cellular
mediat
activ
infectioninduc
inflamm
underli
increas
tau
patholog
characterist
determin
whether
necessari
mediat
inflammationinduc
chang
tau
treat
mice
lithium
potent
inhibitor
found
inhibit
revers
tau
hyperphosphoryl
shift
insolubl
fraction
significantli
treatment
lithium
also
led
improv
cognit
phenotyp
togeth
data
strongli
suggest
viralor
bacterialmedi
infect
may
act
critic
comorbid
factor
tau
patholog
featur
acceler
anim
nontransgen
nontg
mice
maintain
lightdark
cycl
free
access
food
water
studi
ageand
strainmatch
nontg
mice
use
lp
escherichia
coli
sigma
st
loui
mo
dissolv
nacl
concentr
mgml
lp
administ
ip
nontg
mice
dose
mgkg
bodi
weight
twice
per
week
week
n
four
femal
five
male
mice
n
six
femal
six
male
nontg
mice
control
group
mice
receiv
inject
manner
salin
n
six
femal
four
male
mice
n
four
femal
five
male
nontg
mice
amount
lp
inject
adjust
accord
weight
weekli
mice
euthan
hour
last
inject
perfus
icecold
pb
brain
isol
half
brain
fix
paraformaldehyd
half
snap
frozen
dri
ice
store
twelvemonthold
mice
divid
four
group
group
receiv
standard
rodent
chow
salin
inject
n
four
femal
two
male
group
receiv
standard
rodent
chow
lp
inject
n
four
femal
two
male
group
receiv
lithium
chlorid
gkg
contain
rodent
chow
research
diet
new
brunswick
nj
salin
inject
n
four
femal
two
male
group
receiv
lithium
chlorid
contain
rodent
chow
lp
inject
n
four
femal
two
male
lp
mgkg
salin
inject
given
twice
week
week
previous
describ
obviou
weight
loss
observ
period
lithium
intak
estim
mgd
per
mous
base
assumpt
mous
consum
gd
chow
last
week
inject
mice
underw
behavior
test
describ
later
mice
euthan
day
last
inject
perfus
icecold
pb
brain
isol
half
brain
fix
paraformaldehyd
half
snap
frozen
dri
ice
store
evalu
impact
mhv
infect
ad
patholog
characterist
nontg
mice
infect
neuroadapt
jhm
strain
mhv
suspend
hbss
receiv
inject
hbss
alon
sham
control
mice
anesthet
ip
inject
ketamin
mgkg
phoenix
st
joseph
mo
xylazin
mgkg
mp
biomed
llc
aurora
oh
dilut
steril
hbss
anesthet
mice
inject
intracrani
plaqueform
unit
neurotroph
mhv
strain
provid
john
fleme
md
univers
wisconsin
madison
wi
dilut
l
steril
hbss
n
sham
control
anim
inject
l
hbss
alon
develop
behavior
deficit
nophenotyp
fluorescenceactiv
cell
sort
stain
defin
surfac
antigen
use
establish
method
brain
remov
store
ice
ml
dulbecco
modifi
eagl
media
process
tissu
transfer
steril
petri
dish
mash
singlecel
suspens
cell
suspens
transfer
conic
tube
medium
percol
ge
healthcar
uppsala
sweden
ad
final
concentr
medium
percol
ml
underlain
tube
centrifug
g
minut
live
cell
collect
interfac
wash
twice
stain
flow
cytometr
analysi
intracellular
stain
perform
cell
isol
brain
mhvinfect
control
mice
transgen
mice
cell
stimul
moll
peptid
control
antigen
mhv
spike
glycoprotein
residu
stimul
cell
incub
hour
media
contain
golgistop
cytofixcytoperm
kit
bd
bioscienc
point
cell
fc
block
bd
bioscienc
cell
stain
fluoresc
antibodi
bd
bioscienc
follow
cell
surfac
marker
ebiosci
spinal
cord
obtain
experiment
group
day
post
infect
pi
fix
immers
overnight
normal
buffer
formalin
portion
tissu
embed
paraffin
spinal
cord
section
stain
luxol
fast
blue
analyz
light
microscopi
demyelin
score
follow
demyelin
mild
inflamm
accompani
loss
myelin
integr
moder
inflamm
increas
myelin
damag
numer
inflammatori
lesion
accompani
signific
increas
myelin
strip
intens
area
inflamm
accompani
numer
phagocyt
cell
engulf
myelin
debri
slide
contain
stain
spinal
cord
section
blind
score
frozen
brain
halv
homogen
tissu
protein
extract
reagent
pierc
rockford
il
proteas
inhibitor
cocktail
roch
appli
scienc
indianapoli
phosphatas
inhibitor
mmoll
sodium
fluorid
moll
sodium
orthovanad
homogen
centrifug
x
g
hour
supernat
collect
detergentsolubl
fraction
pellet
resuspend
formic
acid
homogen
centrifug
x
g
hour
result
supernat
save
formic
acid
fraction
protein
concentr
determin
bradford
method
equal
amount
protein
g
depend
protein
interest
separ
sdspage
bistri
gel
invitrogen
carlsbad
ca
transfer
polyvinyliden
difluorid
membran
block
hour
vv
nonfat
milk
trisbuff
salin
ph
supplement
tween
fraction
immunoblot
antibodi
recogn
app
total
tau
total
endogen
tau
dako
carpinteria
ca
phosphoryl
tau
pair
helic
filament
pierc
santa
cruz
biotechnolog
santa
cruz
ca
calbiochem
la
jolla
ca
total
cell
signal
beverli
total
bd
bioscienc
antibodi
use
load
control
formic
acid
fraction
neutral
mix
equal
amount
sampl
naoh
neutral
buffer
moll
tri
base
moll
na
hpo
equal
amount
protein
neutral
sampl
separ
sdspage
gel
manner
solubl
fraction
quantif
band
intens
measur
use
softwar
scion
imag
normal
dehydrogenas
total
tau
level
phosphoryl
tau
analys
fix
brain
halv
slice
vibratom
moll
thick
overnight
incub
primari
antibodi
section
quench
hydrogen
peroxid
plu
methanol
permeabil
triton
trisbuff
salin
block
solut
contain
bovin
serum
albumin
incub
primari
antibodi
trisbuff
salin
contain
serum
overnight
slice
wash
triton
trisbuff
salin
incub
appropri
secondari
antibodi
presenc
secondari
antibodi
tissu
reveal
reaction
diaminobenzidin
certain
antigen
requir
special
condit
stain
requir
pretreat
formic
acid
antigen
requir
remov
deterg
antibodi
incub
imag
stain
hippocampu
entorhin
cortex
amygdala
acquir
digit
camera
axiocam
connect
microscop
axioskop
carl
zeiss
microimag
thornwood
ny
softwar
axiovis
plaqu
diamet
count
three
four
random
field
hippocampu
anim
quantit
analyz
plaqu
number
analysi
phosphoryl
taubear
neuron
neuron
subiculum
hippocampu
count
anim
measur
level
equal
amount
protein
g
solubl
fraction
load
directli
onto
enzymelink
immunosorb
assay
elisa
plate
equal
amount
protein
g
formic
acid
fraction
dilut
neutral
buffer
moll
tri
base
moll
na
hpo
load
load
antibodi
concentr
gml
coat
buffer
moll
naco
buffer
ph
coat
onto
immunopl
nunc
napervil
il
plate
block
bovin
serum
albumin
synthet
standard
made
antigen
captur
buffer
mmoll
nah
po
mmoll
edta
moll
nacl
g
l
total
volum
dimethylammonio
bovin
serum
albumin
ph
load
onto
elisa
plate
along
solubl
formic
acid
fraction
sampl
standard
load
duplic
plate
incub
overnight
plate
wash
probe
either
horseradish
peroxidaseconjug
overnight
chromogen
use
tetramethylbenzidin
ophosphor
acid
use
stop
reaction
concentr
sampl
determin
read
nm
detect
level
homogen
brain
elisa
kit
purchas
pierc
protocol
provid
manufactur
follow
briefli
sampl
incub
biotinyl
antibodi
precoat
plate
incub
streptavidinhorseradish
peroxidas
solut
tetramethylbenzidin
chromogen
appli
manufacturersuppli
stop
solut
use
concentr
sampl
determin
read
nm
brain
sampl
immunoprecipit
protein
gagaros
antibodi
protein
aagaros
antibodi
reaction
mixtur
contain
mmoll
acid
ph
mmoll
mgcl
mmoll
sodium
orthovanad
mmoll
naf
moll
atp
ci
p
atp
mmoll
substrat
calbiochem
kinas
assay
mmoll
substrat
calbiochem
assay
allow
reaction
proceed
hour
supernat
place
phosphocellulos
squar
upstat
waltham
wash
phosphor
acid
squar
count
scintil
counter
determin
kinas
activ
apparatu
use
water
maze
task
circular
aluminum
tank
diamet
paint
white
fill
water
maintain
maze
locat
room
contain
sever
simpl
visual
extramaz
cue
reduc
stress
mice
place
platform
second
first
train
trial
mice
train
swim
diamet
circular
clear
plexigla
platform
submerg
cm
beneath
surfac
water
invis
mice
swim
platform
locat
select
randomli
mous
kept
constant
individu
mous
throughout
train
trial
mous
place
tank
one
four
design
start
point
pseudorandom
order
mice
allow
find
escap
onto
submerg
platform
mous
fail
find
platform
within
second
mous
manual
guid
platform
allow
remain
second
afterward
mous
place
hold
cage
warm
lamp
second
start
next
trial
ensur
memori
differ
lack
task
learn
mice
given
four
trial
day
mani
day
requir
train
lithiumuntr
lithiumtr
mice
criterion
second
mean
escap
latenc
first
probe
trial
run
control
overtrain
probe
trial
run
group
soon
reach
group
criterion
group
reach
criterion
retent
spatial
train
assess
hour
hour
last
train
trial
probe
trial
platform
remov
pool
mice
monitor
ceilingmount
camera
directli
pool
period
trial
record
subsequ
analysi
paramet
measur
probe
trial
includ
follow
time
spent
target
quadrant
quadrant
platform
locat
ii
latenc
cross
platform
locat
iii
number
platform
locat
cross
target
quadrant
vari
mice
within
group
control
potenti
differ
salienc
extramaz
cue
data
analyz
use
oneway
analysi
varianc
posttest
includ
dunnett
bonferroni
newmankeul
post
hoc
test
unpair
ttest
p
consid
statist
signific
first
examin
tempor
profil
central
nervou
system
cn
immun
respons
acut
viral
infect
cn
mice
nontg
mice
infect
mhv
via
singl
unilater
inject
hippocampu
induc
robust
neuroinflammatori
respons
character
increas
infiltr
macrophag
high
activ
microglia
low
major
histocompat
complex
class
ii
posit
infiltr
cell
see
supplement
figur
ac
http
ajpamjpatholorg
signific
differ
mortal
infect
nontg
mice
infect
mice
success
control
viral
replic
viral
titer
within
brain
reduc
lower
detect
level
approxim
plaqueform
unit
per
gram
tissu
day
pi
see
supplement
figur
http
ajpamjpatholorg
find
indic
differ
exist
age
agematch
nontg
mice
limit
viral
replic
within
cn
support
observ
differ
detect
secret
resid
cell
within
cn
measur
major
histocompat
complex
class
ii
stain
resid
microglia
see
supplement
figur
http
ajpamjpatholorg
virusspecif
cell
infiltr
cn
measur
secret
peptidestimul
cell
see
supplement
figur
http
ajpamjpatholorg
given
evid
nontg
mice
exhibit
immun
respons
mhv
infect
investig
acut
cn
insult
subsequ
immun
respons
affect
longlast
neuropatholog
chang
brain
spinal
cord
thu
examin
neuropatholog
chang
week
mhv
inject
residu
shortterm
immun
respons
detect
brain
found
detect
demyelin
spinal
cord
nontg
mice
receiv
mhv
inject
shaminject
mice
see
supplement
figur
http
ajpamjpatholorg
mice
also
show
phenotyp
sign
motor
impair
therefor
cognit
test
conduct
mhvinject
mice
base
result
examin
detail
neuropatholog
chang
underli
mechan
mice
earlier
point
week
mhv
inject
age
mice
analyz
effect
tau
patholog
characterist
although
detect
signific
increas
fragment
ctf
fragment
fragment
week
infect
figur
see
also
supplement
figur
http
ajpamjpatholorg
overal
patholog
featur
measur
quantit
elisa
immunostain
alter
point
figur
b
c
howev
mark
exacerb
tau
patholog
characterist
brain
observ
mhv
next
sought
examin
sustain
brain
inflamm
affect
adlik
patholog
characterist
viral
infect
brain
effici
clear
within
day
previous
describ
use
altern
approach
system
inject
lp
repeatedli
mimic
bacteri
infect
treatment
paradigm
induc
robust
inflamm
brain
sever
mous
model
includ
prepatholog
mice
age
mice
age
mice
inject
lp
week
led
mark
increas
brain
inflamm
indic
infiltr
macrophag
microglia
elev
level
proinflammatori
cytokin
see
supplement
figur
ac
http
ajpamjpatholorg
despit
evid
chronic
inflammatori
respons
brain
plaqu
load
appear
similar
lpsinject
salinetr
mice
detect
differ
stain
pattern
plaqu
patholog
featur
use
antibodi
figur
c
app
steadyst
level
unchang
lpstreat
mice
indic
app
process
like
unchang
figur
furthermor
quantit
analyz
level
solubl
insolubl
ie
formic
acid
fraction
elisa
found
level
significantli
differ
lpsand
salinetr
group
figur
base
previou
studi
lp
inject
prepatholog
mice
result
previous
describ
includ
use
singl
mhv
infect
longterm
lp
inject
age
mice
found
chronic
inflamm
appear
significantli
affect
onset
progress
patholog
characterist
unlik
effect
chronic
inflamm
significantli
decreas
tau
steadyst
level
detergentsolubl
fraction
approxim
figur
b
despit
decreas
solubl
tau
level
higher
level
phosphotau
observ
solubl
fraction
lpstreat
mice
figur
b
specif
phosphoryl
site
significantli
increas
twofold
compar
salin
control
lpstreat
mice
phosphoryl
significantli
increas
wherea
phosphoryl
decreas
studi
indic
phosphoryl
may
inhibit
phosphoryl
produc
pattern
phosphoryl
observ
herein
favor
phosphoryl
also
consist
increas
reactiv
epitop
phosphoryl
requir
format
epitop
addit
neuron
markedli
increas
time
mice
expos
chronic
inflamm
figur
c
chronic
inflamm
appear
exacerb
tau
patholog
featur
tau
may
shift
insolubl
fraction
examin
tau
level
insolubl
formic
acid
fraction
lpstreat
mice
observ
signific
increas
detergentinsolubl
tau
figur
b
determin
whether
shift
tau
insolubl
fraction
associ
develop
advanc
tau
patholog
featur
examin
level
tau
significantli
increas
formic
acid
fraction
lpstreat
mice
figur
b
addit
number
neuron
significantli
increas
time
lpstreat
mice
figur
howev
abl
detect
adlik
neurofibrillari
tangl
mice
suggest
increas
accumul
insolubl
tau
lpstreat
mice
could
pretangl
tau
protofibrillar
oligomer
intermedi
tau
may
eventu
turn
neurofibrillari
tanglelik
structur
next
investig
whether
exacerb
tau
patholog
characterist
mediat
aberr
activ
previous
aberr
activ
exacerb
tau
phosphoryl
prepatholog
young
mice
interestingli
studi
observ
signific
decreas
level
lpsinject
age
mice
figur
b
hand
detect
signific
decreas
level
phosphoryl
lpstreat
mice
figur
b
radioact
kinas
assay
confirm
activ
significantli
increas
mice
expos
chronic
inflamm
wherea
signific
differ
activ
salineand
lpstreat
mice
figur
discrep
young
age
mice
may
result
differ
tempor
activ
pattern
brain
least
mous
model
activ
detect
younger
age
peak
approxim
month
decreas
age
wherea
activ
increas
agedepend
manner
age
month
see
supplement
figur
b
http
ajpamjpathol
org
find
collect
show
infectioninduc
inflammatori
respons
brain
play
key
role
exacerb
tau
patholog
featur
dysregul
kinas
activ
particularli
mediat
confirm
increas
activ
underli
enhanc
phosphoryl
tau
induc
lp
older
mice
treat
lpsinject
mice
lithium
wellestablish
potent
inhibitor
similar
previou
experi
lp
mgkg
inject
twice
week
week
mice
one
group
mice
maintain
normal
feed
wherea
anoth
group
given
lithiumenrich
feed
previous
amount
lithium
feed
inhibit
activ
cohort
mice
subject
behavior
task
mice
sacrif
period
brain
harvest
treat
mice
lithium
revers
sever
patholog
effect
chronic
inflamm
particular
phosphoryl
significantli
increas
lithiumtr
mice
indic
success
inhibit
activ
figur
b
observ
signific
threefold
increas
detergentsolubl
tau
level
lithiumtr
mice
along
signific
threefold
decreas
tau
phosphoryl
solubl
fraction
figur
b
addit
insolubl
fraction
tau
significantli
decreas
threefold
compar
mice
treat
lp
figur
c
lithium
treatment
appear
revers
lpsinduc
tau
patholog
characterist
without
alter
load
inflammatori
respons
measur
figur
ac
chronic
inflamm
brain
lpstreat
mice
induc
learn
memori
impair
morri
water
maze
mwm
task
lpstreat
mice
took
lon
ger
reach
criterion
indic
impair
learn
figur
mice
elev
inflamm
also
exhibit
signific
increas
escap
latenc
cross
platform
locat
decreas
number
cross
platform
locat
probe
trial
figur
b
c
comparison
agematch
nontg
mice
receiv
lp
manner
also
exhibit
delay
latenc
cross
platform
locat
probe
trial
yet
much
lower
degre
lpstreat
mice
see
supplement
figur
http
ajpamjpatholorg
number
platform
cross
unlik
mice
differ
sham
lp
treatment
nontg
mice
see
supplement
figur
http
ajpamjpatholorg
endogen
tau
phosphoryl
insolubl
tau
level
concomitantli
increas
lpstreat
nontg
mice
see
supplement
figur
http
ajpamjpatholorg
data
suggest
cognit
much
affect
mice
possibl
presenc
patholog
mutant
tau
exacerb
tau
patholog
characterist
result
part
confirm
fact
lithium
treatment
revers
behavior
impair
induc
chronic
inflamm
mice
treat
lithium
lp
perform
compar
salinetr
anim
mwm
contrast
lpstreat
mice
perform
significantli
wors
salin
control
addit
mice
treat
lithium
lp
significantli
less
latenc
cross
platform
compar
lpstreat
mice
probe
trial
figur
b
c
present
studi
demonstr
acut
chronic
viral
bacteri
infect
modul
brain
inflammatori
respons
markedli
affect
develop
tau
patholog
featur
mous
model
ad
inflammationmedi
exacerb
tau
patholog
featur
lead
impair
cognit
effect
block
inhibit
activ
previous
young
prepatholog
mice
exhibit
increas
tau
phosphoryl
neuron
lpsinduc
inflamm
suggest
sustain
brain
inflamm
trigger
tau
patholog
featur
patholog
role
inflamm
support
anoth
studi
show
inflamm
preced
tau
tangl
format
mous
model
acquisit
curv
train
mwm
lpstreat
mice
requir
train
reach
criterion
b
lpstreat
mice
significantli
increas
latenc
cross
platform
locat
probe
trial
lpstreat
mice
cotreat
lithium
perform
significantli
better
mice
treat
lp
p
p
versu
salinetr
group
p
versu
lpstreat
group
c
lpstreat
mice
also
impair
probe
trial
significantli
increas
latenc
cross
platform
significantli
fewer
platform
cross
versu
salinetr
control
p
versu
salinetr
group
p
versu
lpstreat
group
tauopathi
present
studi
provid
novel
evid
chronic
inflamm
trigger
viral
infect
lp
inject
initi
contribut
progress
tau
patholog
featur
cognit
impair
age
mice
observ
increas
tau
phosphoryl
sever
epitop
includ
increas
detergentinsolubl
tau
accumul
lpsinject
mice
interestingli
howev
abl
detect
tanglelik
patholog
featur
tau
mice
age
increas
detergentinsolubl
tau
somatodendrit
tau
accumul
administr
infecti
agent
may
mediat
increas
format
pretangl
tau
protofibrillar
oligomer
tau
intermedi
may
play
import
role
neuron
loss
synapt
dysfunct
cognit
impair
chang
tau
patholog
characterist
associ
dysregul
kinas
activ
consist
numer
mous
model
show
becom
primari
modul
tau
phosphoryl
mice
age
interestingli
contrast
previou
observ
young
prepatholog
mice
find
signific
decreas
coregul
without
increas
gener
activ
decreas
older
mice
chronic
inflamm
mice
age
becom
regul
activ
studi
show
increas
activ
induc
phosphoryl
site
lead
inhibit
activ
consid
direct
substrat
may
mediat
action
either
upregul
phosphoinositid
pathway
inhibit
protein
phosphatas
thu
decreas
activ
observ
older
mice
chronic
inflamm
may
partli
respons
signific
increas
activ
observ
dysregul
kinas
activ
subsequ
tau
hyperphosphoryl
implic
import
develop
tau
aggreg
ultim
classic
tangl
observ
ad
brain
demonstr
inflamm
part
respons
alter
kinas
activ
brain
exacerb
tau
patholog
featur
neuron
inhibit
lithium
subsequ
blockad
tau
phosphoryl
attenu
detergentinsolubl
tau
improv
cognit
function
mice
previous
signific
rescu
effect
lithium
found
cognit
age
month
mice
discrep
present
studi
may
part
age
mice
significantli
affect
adlik
neuropatholog
cognit
impair
age
use
studi
month
may
still
young
enough
cognit
impair
revers
modul
patholog
chang
thu
data
indic
tau
phosphoryl
import
process
format
pretangl
tau
intermedi
tau
aggreg
neurofibrillari
tangl
addit
data
suggest
hyperact
subsequ
increas
phosphotau
accumul
may
partli
contribut
earli
cognit
impair
mice
hyperphosphoryl
tau
known
reduc
stabil
turn
caus
axon
transport
deficit
integr
axon
transport
system
crucial
maintain
proper
synaps
function
deficit
synaps
function
secondari
hyperphosphoryl
tau
may
underli
cognit
dysfunct
observ
mice
chronic
inflamm
recent
studi
show
inhibit
activ
genet
reduc
level
prevent
memori
reconsolid
contrast
data
show
longlast
elev
activ
impair
learn
memori
consist
studi
show
memori
impair
shortterm
hyperactiv
thu
although
normal
activ
may
necessari
memori
consolid
hyperact
longlast
activ
consequ
hyperphosphoryl
tau
like
detriment
learn
memori
studi
particularli
focus
patholog
involv
tau
patholog
characterist
chronic
inflamm
lithium
use
inhibitor
lithium
may
activ
benefici
pathway
facilit
tau
degrad
lithium
known
inhibit
protein
phosphatas
maintain
phosphoryl
akt
recent
studi
demonstr
lithium
also
activ
autophagi
inhibit
inositol
monophosphatas
autophagi
degrad
aberr
protein
aggreg
cytosol
attenu
diseas
condit
phosphoryl
tau
effect
degrad
lithium
treatment
still
open
question
conclus
find
viral
infect
lpsmediat
chang
brain
inflamm
exacerb
tau
patholog
characterist
cognit
declin
age
mice
immun
respons
alter
becom
dysfunct
age
therefor
infecti
agent
may
detriment
young
individu
immun
respons
properli
regul
becom
deleteri
older
individu
howev
lp
inject
use
studi
complet
mimic
bacteri
infect
cours
action
may
differ
exampl
cours
durat
much
shorter
compar
typic
bacteri
infect
lack
bacteri
foci
may
influenc
host
immun
respons
despit
differ
lp
still
wide
use
surrog
bacteri
infect
action
inflammatori
respons
robust
compar
bacteri
infect
overal
believ
work
signific
show
certain
microbi
infect
may
act
comorbid
factor
ad
base
evid
observ
herein
appear
act
mainli
affect
tau
patholog
featur
exacerb
cognit
declin
